We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Impact of Visceral Fat on the Pathogenesis of Age-related Macular Degeneration

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified January 2013 by Rudolf Foundation Clinic.
Recruitment status was:  Active, not recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT01777984
First Posted: January 29, 2013
Last Update Posted: January 29, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Rudolf Foundation Clinic
  Purpose
The purpose of this study is to determine the relationship among the body fat distribution, especially the visceral fat, in patients with age-related macular degeneration in comparison to patients with a normal fundus.

Condition
Age-related Macular Degeneration

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: Impact of Visceral Fat on the Pathogenesis of Age-related Macular Degeneration

Resource links provided by NLM:


Further study details as provided by Rudolf Foundation Clinic:

Primary Outcome Measures:
  • visceral fat ratio [ Time Frame: 1 day ]

Secondary Outcome Measures:
  • Leptin, Amyloid, TNF alpha, CRP [ Time Frame: 1 day ]

Estimated Enrollment: 100
Study Start Date: December 2009
Estimated Study Completion Date: December 2013
Estimated Primary Completion Date: May 2013 (Final data collection date for primary outcome measure)
Detailed Description:
In this study the investigators want to examine the relationship among visceral fat, serum leptin levels, and high-sensitive CRP (hsCRP), Tnf-alpha, Amyloid alpha and Amyloid Beta serum levels in patients with age-related macular degeneration in comparison to patients with a normal fundus.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   60 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
patients with age-related macular degeneration, over 60
Criteria

Inclusion Criteria:

  • man and women over 18 years old
  • filled informed consent
  • diagnosis of age-related macular degeneration

Exclusion Criteria:

  • inherited retinal disease
  • other acquired retinal macular disease
  • missing informed consent
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01777984


Locations
Austria
Rudolf Foundation Clinic
Vienna, Austria, 1030
Sponsors and Collaborators
Rudolf Foundation Clinic
Investigators
Principal Investigator: Susanne Binder Rudolf Foundation Clinic
  More Information

Responsible Party: Rudolf Foundation Clinic
ClinicalTrials.gov Identifier: NCT01777984     History of Changes
Other Study ID Numbers: EK-08-122-0708
First Submitted: December 1, 2011
First Posted: January 29, 2013
Last Update Posted: January 29, 2013
Last Verified: January 2013

Additional relevant MeSH terms:
Macular Degeneration
Retinal Degeneration
Retinal Diseases
Eye Diseases